Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Moodys
Mallinckrodt
Chinese Patent Office
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
McKinsey

Generated: May 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lamivudine

« Back to Dashboard

lamivudine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Viiv Hlthcare EPIVIR lamivudine SOLUTION;ORAL 020596 NDA ViiV Healthcare Company N 49702-205-48
Glaxosmithkline EPIVIR-HBV lamivudine SOLUTION;ORAL 021004 NDA GlaxoSmithKline LLC N 0173-0663-00
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Rising Health, LLC N 57237-274-24
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Aurobindo Pharma Limited N 65862-055-24
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
Farmers Insurance
Teva
US Army
Harvard Business School
Cantor Fitzgerald
Boehringer Ingelheim
Merck